Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vitastem
- Development stage
- Unknown
- Lead developer
- ViaDerma
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Vitastem is a topical antibiotic ointment whose active ingredient is tetracycline hydrochloride. It is designed for first aid use to help prevent the risk of skin infection in minor cuts, scrapes, and burns. Vitastem has demonstrated efficacy against a broad spectrum of Gram-positive and Gram-negative bacteria, including drug-resistant strains such as MRSA. The product utilizes an advanced topical delivery system developed by ViaDerma to enhance the penetration and effectiveness of tetracycline through the skin barrier. It is intended for external use only and should not be ingested[1][2][4].
- Brand names
- vitastem
- Other names
- tetracycline hydrochloride
02
Targets
Bacterial Ribosome
Beyond the preview
Go deeper on vitastem.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vitastem.